The Incidence and Impact of Vocal Cord Dysfunction In Patients Undergoing Thoracic Surgery
NCT ID: NCT02996526
Last Updated: 2020-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
173 participants
OBSERVATIONAL
2016-09-01
2018-04-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predisection Risk Factors for Vocal Cord Palsy After Total Thyroid Surgery
NCT04986592
Goitres Influence on Voice Function - The Impact of Surgery
NCT02468921
Voice Outcomes Following Thyroidectomy
NCT03657654
Dysphagia in Thoracic Surgical Patients
NCT04487028
Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Construction Approaches
NCT00600223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary: Estimate the prevalence of vocal cord dysfunction after thoracic surgery and the association of vocal cord dysfunction and immediate post operative respiratory complication after thoracic surgery.
Secondary:
1. Estimate the prevalence of vocal cord dysfunction in the pre-operative patient population undergoing thoracic surgery, i.e. the baseline prevalence.
2. Estimate the incidence of new vocal cord dysfunction in the post-operative period, i.e. the incidence of new dysfunction
3. Estimate the association of vocal cord dysfunction and respiratory, voice, swallowing, and mortality outcomes
4. Estimate the impact of vocal cord immobility on hospital length of stay, ICU admission rates and duration
Population: All patients undergoing thoracic surgery at Health Sciences Centre in Winnipeg, Canada. This is a tertiary care centre with a population-based referral base of 1.5 million people
Schematic of Study Design:
Enrollment Vocal Cord Mobility Assessment 1
Total N=141: Obtain informed consent. Screen potential participants by inclusion and exclusion criteria; obtain history Perform Flexible Nasolaryngoscopy by otolaryngology resident, document by videorecording
Vocal Cord Mobility Assessment 2 Post operative day 1-2 Perform Flexible Nasolaryngoscopy by otolaryngology resident, document by videorecording
Collection of functional outcomes Hospital Discharge or Death Collection of data on respiratory, voice, swallowing, cardiovascular mortality outcomes, hospital length of stay and ICU admission duration
Review of Vocal Cord Mobility Assessment by expert (Laryngologist) by review of videorecordings of nasolaryngoscopy
Statistical Analysis Final Assessments Association of vocal cord immobility and functional outcomes and death.
2.1 Background Information Research Question: In patients undergoing thoracic surgery, what is the incidence of respiratory and associated complications in the 30 day post-operative period among those with/without Recurrent Laryngeal Nerve (RLN) Injury?
Background: The issue of RLN injury is an important clinical challenge in thoracic surgery, as respiratory complications are the greatest source of morbidity in our surgical population . Clinical care experience and the literature demonstrate a high incidence of respiratory complications (20-60% incidence of pneumonia for esophagectomy and a 20% death rate for those who contract pneumonia) in the post-operative thoracic surgery population.
The thoracic surgery population is at uniquely elevated risk for respiratory complications due to the high prevalence of COPD, the nature of the primary surgical procedure directly diminishing pulmonary function and toilet; and possible RLN injury. The only modifiable element of this triad is RLN injury, and appears to be the most important element based on clinical experience and the limited literature available. The RLN supplies motor innervation to the vocal cords; vocal cord closure is considered the most important protective mechanism against aspiration into the lungs . Patients with a RLN injury demonstrate a 5-fold risk of contracting pneumonia, a 5-fold risk of reintubation or tracheostomy , and have 40-60% longer hospital stays than patients without RLN injury.
The current literature base is substantially lacking with regards to the incidence of RLN injury, with estimates varying from 4-80% based on retrospective reviews or prospective studies which fail to examine all patients. The highest quality studies demonstrate a RLN injury rate in the range of 20-40% for major procedures such as esophagectomy and pneumonectomy.
With the recent advent of injection laryngoplasty for vocal cord medialization, there is now a practical means of potentially altering the course of this pathologic triad. This procedure can be performed at the bedside under local anesthetic, allowing for early intervention in this high-risk population as a bulwark against aspiration.
Prospectively examining the incidence of pre and post-operative vocal cord immobility in all thoracic surgery patients is the only means to quantify the health burden associated with RLN injury.
Potential Risks Potential risks of the study include time involved in considering participation, providing consent and data such as subjective voice quality and undergoing flexible nasolaryngoscopy to assess vocal cord status. No health, economic or legal risks are anticipated for the participants.
Potential Benefits No direct benefit, either monetary or health improvement will accrue to patients from participation in the study.
Study Outcome Measures Vocal Cord Mobility - Flexible nasolaryngoscopy to visualize mobility status of vocal cords.
Voice - Voice Handicap Index 10. Validated instrument used for subjective assessment of voice, 10 plain language questions answered by the patient.
Respiratory: Incidence of pneumonia (as defined by CDC criteria) and intubation Swallowing: Oral diet vs NPO and diet texture tolerated at discharge Cardiovascular: Myocardial Infarction as defined by the third universal criteria 2012 by third ESC/ACCF/AHA/WHF, Cerebrovascular Accident as defined by WHO MONICA criteria and Neurology specialist consultation
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intact Vocal Cord Mobility
Patients with normal laryngeal function post thoracic surgery
No interventions assigned to this group
Vocal Cord Dysfunction
Patients with abnormal vocal cord movement of 1 or both vocal cords post thoracic surgery
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
* Provide signed and dated informed consent form.
* Willing to comply with all study procedures and be available for the duration of the study.
* Male or female, aged 18 and over..
* Have a condition requiring surgical entry into the thoracic cavity
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manitoba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sadeesh Srinathan, MD
Dr. Sadeesh Srinathan Associate Professor Section of Thoracic Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sadeesh Srinathan, MD
Role: PRINCIPAL_INVESTIGATOR
University of Manitoba
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Sciences Centre
Winnipeg, Manitoba, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SSMGAD2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.